22–23 Jul 2026
Heidelberg Congress Center
Europe/Berlin timezone

Digital Physical Activity Surveillance and Personalized Counseling for Cardiovascular Prevention in Survivors of Childhood and Adolescent Hodgkin Lymphoma – Design of the Cardio-HOPE Randomized Controlled Trial

Not scheduled
30m
Heidelberg Congress Center

Heidelberg Congress Center

Czernyring 20 69115 Heidelberg Germany
1 - Scientific Poster Poster Session

Speaker

Dr Sabine Kesting (Technical University of Munich, Germany; TUM School of Medicine and Health, Department of Pediatrics. German Center for Child and Adolescent Health (DZKJ), partner site Munich, Germany)

Description

Background: Survivors of childhood and adolescent Hodgkin lymphoma (HL) exposed to cardiotoxic therapy face a substantially increased risk of long-term cardiovascular morbidity. Physical activity (PA) is a key modifiable risk factor for cardiovascular risk reduction; yet, sustainable PA promotion in survivorship care remains challenging. The Cardio-HOPE study evaluates whether digitally supported, personalized counseling can increase moderate-to-vigorous physical activity (MVPA) in HL survivors through a 6-month intervention combining graded PA promotion, individualized live counseling, and continuous monitoring.
Methods: This randomized, controlled, open, three-arm multicenter trial aims to enroll 200 HL survivors diagnosed before age 21, treated with anthracyclines and chest irradiation, ≥ 5 years post-treatment without manifest cardiovascular disease. Following exercise and cardiological assessment to determine physical performance and medical eligibility, participants will undergo a 4-week baseline assessment using wearable-based monitoring, medical, and daily-life parameters for stratification according to PA levels and are randomized (1:1:1) to: (1) control group receiving a wearable without feedback, (2) intervention group 1 receiving a wearable and monthly general PA information, or (3) intervention group 2 receiving a wearable plus personalized PA counseling over 6 months. Primary endpoint: Objectively measured MVPA increase at 6 months. Secondary endpoints: MVPA, sedentary time, adherence to international PA guidelines at 3, 6, and 9 months.
Perspective: This approach integrates exercise oncology expertise into a digital health application, enabling continuous monitoring of PA and functional performance in daily life. Personalized counseling is based on objectively assessed performance and digital activity data. The intervention combines structured feedback, behavioral support, and individualized PA recommendations to facilitate long-term adherence in cardio-oncology survivorship care. Cardio-HOPE will provide evidence on the effectiveness of personalized digital PA interventions to increase MVPA among HL survivors and support implementation of individualized exercise-based cardio-oncology survivorship care pathways.
Acknowledgments: Funded by the German Federal Ministry for Research, Technology, and Space (16SV9594).

Keywords

physical activity promotion
cardiovascular prevention
digital health intervention
cancer survivorship

Abstract submitters declaration yes
Conflict of Interest & Ethical Approval yes

Authors

Dr Sabine Kesting (Technical University of Munich, Germany; TUM School of Medicine and Health, Department of Pediatrics. German Center for Child and Adolescent Health (DZKJ), partner site Munich, Germany) Dr Diana Richter (Department of Oncology, University Cancer Center Leipzig (UCCL), Cancer Survivorship Working Group, Leipzig University Hospital, Leipzig, Germany) Mrs Carla Bähr (Department of Oncology, University Cancer Center Leipzig (UCCL), Cancer Survivorship Working Group, Leipzig University Hospital, Leipzig, Germany) Prof. Karsten Krüger (Department of Exercise Physiology and Sports Therapy, Institute of Sports Science, Justus-Liebig-University Giessen, Giessen, Germany) Dr Ester J. Herrmann (Medical Clinic I, Cardiology and Angiology and Department of Cardiac, Paediatric Cardiac and Vascular Surgery, Justus Liebig University of Giessen) Prof. Stephanie Roll (Institute for Biostatistics and Informatics in Medicine and Ageing Research, Rostock University Medical Center, Rostock, Germany) Prof. Denys Matthies (Technical University of Applied Sciences Lübeck and Fraunhofer IMTE, Lübeck, Germany) Prof. Judith Gebauer (Department of Oncology, University Cancer Center Leipzig (UCCL), Cancer Survivorship Working Group, Leipzig University Hospital, Leipzig, Germany) Dr Magdalena Balcerek (Department of Oncology, University Cancer Center Leipzig (UCCL), Cancer Survivorship Working Group, Leipzig University Hospital, Leipzig, Germany)

Presentation materials

There are no materials yet.